COVID-19 and the differences in physiological background between children and adults and their clinical consequences

L Kapustova1, O Petrovicova, P Banovcin

  • 1Clinic of Pediatric Pneumology and Phthisiology, Faculty of Medicine, Slovak Medical University, National Institute of Children's Diseases, Bratislava, Slovak Republic. zuzana.rennerova@nudch.sk and Clinic of Pneumology and Phthisiology, Clinic of Paediatrics, Department of Clinical Immunology and Allergology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, University Teaching Hospital in Martin, Martin, Slovak Republic. jesenak@gmail.com.

Physiological Research
|December 16, 2021
PubMed

Insights

Children exhibit milder COVID-19 outcomes due to a robust innate immune response and trained immunity. Factors like vaccine effects and vitamin D may also contribute to better pediatric outcomes from SARS-CoV-2 infection.

Area of Science:

  • Immunology
  • Pediatrics
  • Infectious Diseases

Background:

  • The SARS-CoV-2 pandemic has impacted all age groups globally.
  • Children represent a small percentage of COVID-19 cases, typically experiencing milder disease and higher survival rates than adults.

Purpose of the Study:

  • To investigate the underlying immunological mechanisms contributing to the milder course of COVID-19 in children.
  • To explore factors influencing the differential disease severity between pediatric and adult populations.

Main Methods:

  • Review of current literature on pediatric and adult immune responses to SARS-CoV-2.
  • Analysis of proposed mechanisms including innate and adaptive immunity, receptor expression, and effects of prior vaccinations and vitamin D.

Main Results:

  • Children generally possess a stronger innate immune response and trained immunity, enabling early infection control.
  • Adults with severe COVID-19 often show suppressed adaptive immunity and dysfunctional innate responses, potentially linked to immunosenescence.
  • Differences in SARS-CoV-2 receptor expression and the influence of live attenuated vaccines and vitamin D prophylaxis in younger children are noted.

Conclusions:

  • Pediatric resilience to severe COVID-19 may be attributed to enhanced innate immunity and trained immunity.
  • Further research in larger cohorts is necessary to validate proposed mechanisms and fully understand SARS-CoV-2 pathogenesis in children.

Related Concept Videos

COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
678
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
15
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
12.7K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
24
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
15
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.5K